Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2024 Apr 8;14:1377858. doi: 10.3389/fonc.2024.1377858

Corrigendum: Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

Reem Altaf 1, Umair Ilyas 2, Anmei Ma 3,4, Meiqi Shi 3,*
PMCID: PMC11033737  PMID: 38651145

In the published article, there was an error in affiliation of Meiqi Shi. Instead of “4Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China”, it should be “3Department of Medical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China”.

The authors apologize for this error and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES